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Summary 
Mature CD4 + helper T lymphocytes have been categorized into two major functional pheno- 
types, T.1 and T.2, which produce distinct arrays of lymphokines and which are thought to 
arise from a pluripotential precursor cell termed T.0. Clonal anergy can be induced in TH1 clones 
by stimulating via the T cell receptor (TCR) complex in the absence of a costimulator molecule; 
however, anergy has been difficult to demonstrate in T.2 clones. We show here that treatment 
of cloned T.0 lines with anergizing stimuli results in the selective loss of T.1 characteristics 
and retention of a T.2 phenotype. Treated cells exhibit a substantial reduction in interleukin 
2 (IL-2) production and antigen-specific cytolytic activity, but retain comparable IL-4 and IL-5 
production in response to restimulation via the TCK complex. T.0 clones exposed to anergizing 
stimuli  also  increase  in  size, thus  morphologically resembling  T.2  cells. The  signaling 
characteristics of these cells also are altered, in that they exhibit an devated basal level of intracellular 
free calcium which fails to increase significantly with subsequent restimulation, reminiscent of 
the signaling characteristics  of T.2 cells. "Anergized" T.0 clones thus share several functional, 
morphologic, and physiologic properties with cells of the T.2 phenotype, suggesting that T.2 
cells may arise when T.0 cells are stimulated via the TCR complex in the absence of a putative 
costimulator molecule. 
H 
elper T  lymphocytes (HTL) 1 perform most of their 
effector  functions via  the  activity of secreted  lym- 
phokines. Cloned CD4 + HTL lines can be segregated into 
at least two mature subsets,  termed T.1 and T.2,  on the 
basis of the array of secreted lymphokines. T.1 cells uniquely 
produce IL-2, lymphotoxin, and IFN-3,, whereas T.2 cells 
uniquely produce IL-4, IL-5, IL-6, and IL-10. Cells of both 
types can produce IL-3, TNF-cz, and GM-CSF (1, 2). This 
distinction based on secreted lymphokines corresponds to func- 
tional  phenotype. T.1  cells  appear  to  be responsible for 
delayed  type  hypersensitivity reactions  and  activation  of 
CD8 + cytolytic T  lymphocytes, whereas T.2 cells are op- 
timal at providing help for B cell proliferation and Ab produc- 
tion, particularly of the IgE and IgG1 isotypes (3, 4). The 
T.1 and T.2 subsets,  therefore, might mediate what have 
been traditionally referred to as the cellular and humoral classes 
of immune response,  respectively. 
Several lines of evidence have suggested that the mature 
T.I  and T.2  cell phenotypes are not present among the 
population of naive  peripheral  CD4 +  lymphocytes, but, 
1 Abbreviations used in this  paper: [Ca  2  +  ]i, intracelluhr free calcium; HTL, 
hdper T lymphocyte;  PLC, phospholipase C. 
rather, differentiate from that population after a primary ac- 
tivation event. Murine CD4 + splenocytes produce predom- 
inantly IL-2 but little or no IL-4 or IFN-3' when initially 
stimulated via the TCR complex (5, 6). However, upon sub- 
sequent restimulation, that population secretes lymphokines 
characteristic  of both the TH1 and T.2 subsets (5-7). When 
doned lines are derived from a bulk population of antigen- 
primed lymphocytes, three predominant types of cell are ob- 
tained: T.1 cells, T.2 cells, and a third type, designated T~0, 
which continues to produce lymphokines  characteristic of both 
mature subsets  (5, 8). The relative proportion of each cell 
type obtained depends on the exogenous lymphokines present 
during the activation event or cloning procedure, and prob- 
ably depends on the type of APC present as well (5, 9-11). 
Many T~0 clones,  when maintained in culture for several 
weeks, eventually simplify their lymphokine profile and ac- 
quire a more typical T.1 or T.2 phenotype (5, 8). Collec- 
tively, these observations have suggested a model in which 
a  resting  CD4 +  T  cell,  upon primary  stimulation with 
specific antigen, differentiates into a pluripotential T~0 cell. 
This cell, under the influence of additional factors such as 
exogenous lymphokines  and costimulatory molecules expressed 
by APCs, differentiates  into a mature T.1 or T.2 effector 
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tiation process on a clonal level remain  undefined. 
We have shown previously that TH1 and T.2 clones dif- 
fer with  respect  to  their  TCK-associated  signal  transduc- 
tion events.  The generation of substantial levels of inositol 
phosphates  and  the  elevation  of intracellular  free calcium 
([Ca2+]i)  that  are readily detected after stimulation  of T.1 
cells  via the TCR complex are not  observed in  T.2  cells 
(13). Preliminary results have revealed that this difference may 
be secondary to differential expression of a particular isoform 
of phospholipase  C (PLC), PLC~I (Goldfien,  R., J. Imboden, 
T. Gajewski, and D. Qian, unpublished observations). In ad- 
dition, lymphokine production by T.1 cells is substantially 
more sensitive to elevations in intracellular  cAMP than is lym- 
phokine  production  by T.2  cells  (13).  The  distinct  signal 
transduction characteristics of T.I and T.2 clones probably 
relate to the unique function  of each of the subsets. 
Stimulation of T.1 cells via the TCR complex in the ab- 
sence of an APC-derived costimulator molecule results, para- 
doxically, not in activation,  but rather  in an unresponsive 
state termed donal anergy (14-16). This process is analogous 
to the generation of peripheral tolerance of T  lymphocytes 
that  have escaped thymic clonal deletion in vivo (17),  and 
is characterized by an inability to secrete IL-2 upon subse- 
quent restimulation. Interestingly,  anergy with respect to IL-4 
production by T.2 clones cannot be similarly induced (18), 
nor is the proliferation of those cells inhibited by anergizing 
stimuli (19,  20), perhaps as a consequence of their distinct 
signaling mechanisms.  In this study, we have examined the 
effect of anergizing stimuli on the functional properties and 
signaling characteristics  of T.0 HTL clones.  After induction 
of anergy, IL-2 production and antigen-specific cytolytic ac- 
tivity of these cells are specifically  inhibited, but the ability 
to secrete IL-4 and IL-5 is preserved, consistent with a func- 
tional transition to a T,2-1ike cell.  Moreover, these cells in- 
crease in size,  exhibit increased basal levels of [Ca  2  +  ]i, dis- 
play minimal  further  increases  in  [Ca2+]1 after subsequent 
restimulation,  consistent with a transition to a T.2-1ike sig- 
naling phenotype. Our observations support a model in which 
T.2 cells might arise when a T.0 intermediate is stimulated 
via the TCR complex in the absence ofa costimulator signal. 
They also predict that attempts to induce anergy by similar 
methods in vivo may actually generate a T.2-driven immune 
response rather  than  peripheral  tolerance. 
Materials  and Methods 
Animalt  Female  DBA/2, BALB/c, and CBA/J mice were pur- 
chased from Tbe Jackson Laboratory (Bar Harbor, ME). Mice were 
housed in a barrier facility and used between 6 and 12 wk of age. 
Culture Media and Reagents.  T  cells were grown in culture 
medium consisting of DMEM plus 5% beat-inactivated FCS, 10 
raM 3(N-morpholino)propane  sulLfonic  acid, 5  x  10  -s M 2-ME, 
100 U/m] penicillin plus 100/~g/ml streptomycin, and additional 
amino acids (21). The CTLI.-2 line used for lymphokine assays and 
the B lymphoma line LK35.2 were grown in the same complete 
medium containing 10% FCS. OVA, conalbumin, digitonin,  Con 
A, and 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium  bro- 
mide (MTT) were purchased from Sigma Chemical Co. (St. Louis, 
MO). Ionomycin and Indo-1 acetoxymethylester were purchased 
from Calbiochem-Novabiochem/Corp.  (San Diego,  CA). 
RecombinantLyraphokinesandrnA~  Recombinant routine IL-2 
and mutine IL-4 were kindly provided by the DNAX Research In- 
stitute of Molecular and Cellular Biology (Palo Alto, CA). Recom- 
binant  human  IL-2 was  generously  provided  by Cetus  Corp. 
(Emeryvilh, CA). Human rlL-2 was used for derivation and main- 
tenance of T cell clones; murine  rlL-2 was used as a standard in 
the Ib2 bioassay. All concentrations are expressed in units per mil- 
liliter as defined by the supplier of each of the lymphokines. Hy- 
bridoma lines 11Bll (anti-Ib4) (22) and S4B6 (anti-IL,2) (2) were 
kindly provided by Dr.  W. Paul (National  Institutes  of Health, 
Bethesda, MD) and Dr. T. Mosmann (DNAX), respectively. The 
145-2Cll (anti-CD3-e)  hybtidoma cell line was kindly provided 
by Dr. J.  Bluestone (University of Chicago)  (23). 
T Cell Clones.  The OVA-reactive T.0 clones and the T.1 clone 
PGLIO were derived from DBA/2 and BALB/c mice using methods 
described  previously  (5).  The  conalbumin-specific  T.2  clone 
D10.G4.1 was obtained from Dr. C. Janeway (Yale University, New 
Haven, CT), and has been described (24). Cloned cells were main- 
tained by weekly restimuhtion with irradiated (2,000 tad) syngeneic 
spleen cells, antigen,  and riD2. For experiments, ceils were har- 
vested 7-10 d after passage, and purified by centrifugation  over a 
Ficoll-Hypaque gradient  (25). 
Isolation of Splenic B Cells.  Adherent cells were removed by in- 
cubating  10  s spleen cells in tissue culture  dishes (model 3003; 
Falcon Labware, Oxnard, CA) in complete medium containing 5% 
FCS at 37~  for 1.5 h. Nonadherent cells were recovered by gentle 
rinsing, and transferred to a glass tube (Vacutainer 6430; Becton 
Dickinson & Co., Rutherford, NJ) which had previously been au- 
toclaved with 0.2 mg carbonyl iron (9). After incubation at 37~ 
for 1.5 h, the contents  of the tube were gently resuspended and 
iron was retained in the bottom of the tube with a magnet while 
the cell suspension was removed with a pipette. Residual iron par- 
ticles were removed by slow centrifugation  (600 rpm for 30 s). T 
cells and residual macrophages were removed by incubation with 
the AT83A (anti-Thyl) and M1/70 (anti-MAC-I) mAb along with 
Low-Tox guinea pig complement  (Accurate Chemical & Scientific 
Corp., Westbury, NY) for 1 h at 37~  The final cell suspension 
was purified by Ficoll-Hypaque centrifugation.  The resulting cell 
population typically consisted of >95% B cells as assessed  by flow 
cytometry using anti-Ig  and anti-B220 Abs (data not shown). 
Induction of Anergy.  For treatment  with anti-CD3  mAb, cul- 
ture wells of 24 well plates (Linbro 76-033-055; Flow Laborato- 
ries, McLean, VA) were coated overnight at 37~  with 0.5 ml of 
goat anti-hamster  antiserum  (Cooper Biomedical, Malveru, PA) 
at a concentration  of 40/~g/ml in Dulbecco's PBS (DPBS) (26). 
They were then washed twice with 1 ml DPBS and received 0.5 
ml of a 1:20 dilution of 145-2Cll hybridoma superuatant in DPBS 
and incubated at 37aC for 2 h. After again washing twice, each 
well received 106 cloned T  cells in a final volume of 1 ml.  For 
other anergy treatments, cells were stimulated with Ionomycin (1 
/~M) or purified B cells (6  x  106) and OVA (800/~g/ml).  Cells 
were collected 24-72 h later, purified by Ficoll-Hypaque centtifu- 
gation, and assayed for functional and biochemical characteristics. 
Cell yield varied from 40 to 90% of the original number of cells 
cultured. For lyraphokine assays, supernatants were collected after 
21-24 h at 37~  centrifuged  to remove cells, and stored at 4~ 
until  assayed. 
T Cell Cytolytic Assays.  Cloned cells were mixed at the indi- 
cated  effector/target  cell ratios  with  SlCr-labeled, OVA-pulsed 
LK35.2 cells, as described (27). Chromium release was assessed at 
5h. 
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using an ELISA develol~l  by Dr. R. Schreiber (Washington Univer- 
sit),, St. Louis, MO) (28), who also generously provided the neces- 
sary reagents. Activity in culture supernatants was compared to 
that in a standard (kindly provided by the National Institute of 
Allergy and Infectious Diseases, No. Gg02-901-533).  ID5 was mea- 
sured with a specific ELISA, using reagents generously provided 
by Dr. R. Coffman (DNAX). I1,2 and Ib4 concentrations were 
determined using a subclone of the CTLb2 indicator line that 
proliferated well in response to either lymphokine. Serial dilutious 
of test supernatants were compared with dilutions of known con- 
centrations of recombinant standards  in the presence of anti-Ib2 
mAb, anti-IL-4 mAb, both mAbs, or neither. Cell viability was 
assessed using the colorimetric MTT assay (29). 
Analysis of Cells by Flow Cytometry.  Cells (2  x  10  s) purified 
by Ficoll-Hypaque centrifugation were stained at 4~  with FITC- 
coupled anti-CD4 (GK1.5), anti-CD3-e (145-2Cll), or anti-TCR- 
(x/fl (H57-597) mAbs in PBS containing 0.1%  BSA and 0.1% 
sodium azide. Cells were analyzed using a FACScan  |  (Becton Dick- 
inson & Co.,  Mountain View,  CA); data were collected on 104 
viable cells and plotted as a histogram of frequency versus fluores- 
cence intensity. 
Measurement of lntracellular Free Calcium.  Cells were incubated 
in complete medium containing 5% FCS with 8 pJC[ Indo-1 acetox- 
ymethylester for 1 h at 37~  at a final concentration of 2  x  107 
cells/ml. They were then washed with DMEM and incubated for 
an additional 30-60 min at 37~  in fresh complete medium. CeUs 
were  again  washed,  resuspended  at  106  cells/m1  in  complete 
medium, and maintained in this medium until analysis. For anal- 
ysis, cells were resuspended in 2 ml of a buffer consisting of 150 
mM NaCI, 5 raM KC1, 1.2 mM MgCh, 10 mM glucose,  10 mM 
MOPS, 0.3% BSA, and 1 mM CaCI2. Fluorescence measurements 
were made on samples maintained at 37~  using a spectrofluoro- 
meter (model LB-S5; Perkin-Elmer Corp., Norwalk, CT). Indo-1 
fluorescence was excited at 330 nm (10-urn bandwidth), and emis- 
sion was measured at 400 nm (10 nm bandwidth). Con A was used 
at a final concentration of 10 ~tg/ml. Cells were lysed with dlgitonln 
to determine Fro, and Fm was determined by addition of 4 mM 
EGTA and sufficient  Tris base to raise the pH above 8.3. [CaZ+]i 
was calculated using the formula: [CaZ+], =  Kd[(F -  F=i~)/(F~ 
-  F)], where Ka =  250 nM and F  =  measured fluorescence (30). 
Results 
Anti-CD3  mAl~ Ionomycin, or B  Cells Plus Antigen Induce 
a Subsequent  Defect  in  IL-2  but not IL-4 Production by  T,O 
Clones.  Unresponsiveness with respect to IL-2 production 
can be induced in T.1 clones with several different stimuli 
that activate the TCK-mediated signaling pathway in the ab- 
sence of fully competent APCs (16). However, IL-4 produc- 
tion by T.2 dories is little affected by similar treatments (18, 
19, and Gajewski, T., unpublished observations). Since these 
cell types appear to possess several differences in their TCR- 
associated signaling mechanisms (13), it was conceivable that 
the selective effect on IL-2 but not IL-4 production resulted 
from an anergizing signal being generated in T.1 but not 
T.2 cells rather than the lack of a response of the IL-4 gene 
to the anergizing stimulus. To address this question, we ex- 
amined the effect of anergizing stimuli on subsequent respon- 
siveness of T.0 clones, which produce both IL-2 and IL-4. 
The cell lines used were believed to be donal based on lim- 
iting dilution frequency anal)sis, homogeneous morphology, 
and the fact that  they were recloned early after derivation 
by micromanipulation  (data  not  shown).  Five T.0 clones 
isolated from BALB/c mice were stimulated for 24 h  with 
immobilized anti-CD3 mAb, purified by Ficoll-Hypaque cen- 
trifugation,  then restimulated with anti-CD3  mAb for as- 
sessment of lymphokine production. Control cells were ei- 
ther harvested directly from passage cultures or incubated 
overnight in culture medium alone, with similar results. As 
shown in Fig.  1 A, cells pretreated with immobilized anti- 
CD3  mAb  produced only 0-10%  of the  amount  of IL-2 
secreted by control cells.  In contrast,  IL-4 production was 
minimally affected, vax~g from 50 to 200% of control values. 
No detectable cytokines were produced when anergized T.0 
cells were restimulated with culture medium alone (data not 
shown),  suggesting that  IL-4 secretion was not persisting 
from the initial exposure to anti-CD3  mAb during the in- 
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Figure  1.  Treatment  of T.0 clones with anergizing stimuli results in 
a subsequent defect in II..2 but not IL.4 production. The five T.0 clones 
listed (106/well) were stimulated for 24 h with either immobilized anti- 
CD3 mAb (/1), Ionomycin (1/~M) (B), or syngeneic splenic B cells (6 
x 10  ~) and OVA (800/zg/ml) (C); control cells for each were maintained 
in rIL-2 (2 U/ml) for the same time period. Cells were then purified by 
Ficoll-Hypaque  centrifugation, restimulated with immobilized anti-CD3 
mAb, and supernatants were collected and assessed for ID2 and IIr4 con- 
centrafions. Results are presented as percent control values, and are repre- 
sentative of two to four e~periments. Control levels of lymphokines for 
this experiment (units per milliliter) were as follows: clone 14: II.r2, 200; 
IL-4, 310,000. Clone 15: lit2, 7; IL-4, 35,000. Clone 28: II.r2, 460; II.r4, 
6,700. Clone 32: IIr2, 1,200; IIr4, 9,300. Clone 33: IIz2, 16; IIr4, 10,000. 
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cultured with anti-CD3 mAb for 72 h or 7 d (data not shown), 
suggesting that the lack of effect on IL-4 production was 
not a result of slower kinetics of inhibition of this lymphokine, 
and also that the inhibition of IL-2 production was not related 
to a transient unresponsive state occurring during early acti- 
vation events. In addition, when treated cells were removed 
from the Ab, rested in culture medium for 7 d, and restimu- 
hted with anti-CD3 mAb, they continued to produce dra- 
matically reduced levels of IL-2 compared to control cells (data 
not shown), arguing that the induced phenotype  was relatively 
long-lived, as has been demonstrated for T.1 clones  (14). 
Induction of unresponsiveness  to T.1 cells with respect 
to IL-2 production appears to be calcium dependent and can 
be mimicked with the calcium ionophore, Ionomycin (31). 
It was conceivable that the T.0 clones generated a sufficient 
increase in [Ca  2  +  ]i to inhibit subsequent production of IL-2 
but not IL-4. Therefore, we examined the effect of Ionomycin 
pretreatment on subsequent lymphokine production by the 
T.0 clones. As shown in Fig.  1 B, Ionomycin also impaired 
the ability of these cells to produce IL-2 but not IL-4 when 
restimulated via the TCR complex. In fact, Ionomycin typi- 
cally enhanced subsequent IL-4 production, exaggerating fur- 
ther the new lymphokine  profile produced  by the treated cells. 
We also determined if T.0 cells could be anergized with 
a more physiologic stimulus. It has been shown that anergy 
can be induced in T.1 clones with specific peptide presented 
by chemically treated spleen cells, purified dams  II MHC mol- 
ecules in planar membranes, or purified resting B cells (16, 
32, 33).  We chose purified B cells as APCs for our system 
because they might represent one cell type that can induce 
anerg'y in vivo, and because they effectively stimulate prolifer- 
ation of T.2 but not T.1 clones in vitro (10). As depicted 
in Fig.  1 C  for three T.0 clones,  exposure to antigen and 
purified B cells also induced subsequent decrease in IL-2 but 
not IL-4 production. These results suggest that TO) calls 
that encounter B cells presenting the rdevant antigenic pep- 
tide during an immune response in vivo might subsequently 
produce IL-4 but substantially less IL-2, effectively trans- 
forming the T  cell phenotype to a T.2-like response. 
Effect of  Anergizing Stimuli on Production  of  Additional Lym- 
phokines by T.O Clones.  Studies of anergy with T.1 clones 
have suggested that, whereas IL-2 production and prolifera- 
tion are dramatically reduced after induction of the anergic 
state,  production of other lymphokines, such as IL-3 and 
IFN-'y, is marginally affected (16). Therefore, we next exam- 
ined the effect of anergizing stimuli on the production of 
additional lymphokines by T.0 clones.  For these studies,  a 
new panel of clones  was derived from DBA/2  mice, and 
screened for the production of IFN-'y in addition to IL-2 and 
IL-4. As shown in Fig. 2, two subtypes of TH0 clones were 
obtained, one which produced IFN-3, and the other which 
did not. In addition, it was noted that the frequency of IFN- 
3,-producing T.0 clones,  as well as  the concentration of 
IFN-'y produced by individual clones,  was increased if the 
cells were derived in the presence of exogenous IFN-3' (Fig. 
2). T.0 clones that produced IL-2 and IL-4 were designated 
T.0-A cells, and those that produced IL-2, IL-4, and IFN-'y 
Figure  2.  Effect of exogenous IFN-'y  on production of IFN-'y  by newly 
derived T.O clones. OVA-specific HTL clones were derived in the pres- 
ence of syngeneic splenocytes, OVA, and either IL-2 (/eft) or IL-2 and IFN~ 
(right)  as described previously (5). Eight clones that produced both Ib2 
and II~4 from each group were analyzed for IFN-~/production  by spedfic 
ELISA after stimulation with anti-CD3 mAh. 
were designated T.0-B cells, a nomenclature suggested pre- 
viously (34).  All T.0 dones examined also produced IL-3, 
IL-5, and TNF activity (data  not shown). 
T.0-A and T.0-B clones were treated for 72 h with anti- 
CD3 mAb, then assessed for the ability to produce multiple 
lymphokines upon restimuhtion with anti-CD3 mAb. As 
shown in Fig. 3 for two TO clones of each subtype, produc- 
tion of IL-2 was completely inhibited by prior exposure to 
anti-CD3 mAb. In contrast, the ability to produce IL-4, IL-5, 
and IPN~ was little affected  by the anergizing stimulus. Sinai- 
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Figure  3.  Effect of pretreatment with immobilized anti-CD3 mAb on 
the subsequent  production of additional lymphokines by I".0 cells. Two 
representative  Td)-A and Td)-B clones were either harvested from main- 
tenance cultures or anergized for 72 h with anti-CD3 mAb, restimulated 
with anti-CD3 mAb, and supernatants were assayed for IL-2, IL-4, Ib5, 
and IFN-'y. Results are representative of two experiments, and similar results 
were obtained with several additional T.0 clones. 
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exposure to anti-CD3 mAb (data not shown). The T.0-A 
clones that did not produce IFN-~/in the resting state did 
not acquire the ability to produce IFN-'y after pretreatment 
with anti-CD3 mAb. Similar results were obtained for sev- 
eral additional T.0 clones of each subtype (data not shown). 
These results suggest that the anergizing signal exerts a po- 
tent inhibitory effect that is relatively specific for production 
of IL-2. Effects on secretion of additional lymphokines are 
modest and vary between individual clones. In addition, since 
the ability to produce both IL-4 and IL-5 persists, they sug- 
gest that a functional T.2-1ike phenotype could be retained 
after exposure of T.0-A cells to anergizing stimuli. 
T.O Cells Anergized with Anti-CD3 raAb Have Diminished 
Antigen-sI~cific Cytolytic Activity.  Inasmuch as the lymphokine 
profile of anergized T.0 cells had retained a T.2-1ike pattern, 
it was of interest to examine other functional procedures as 
well. The great majority of T.0 and T.1 clones derived in 
our laboratory exhibit substantial  antigen-specific  cytolytic 
activity.  For T.0 cells, cytolytic activity usually is greater if 
the cells produce IFN-3r as well (35,  and data not shown). 
In contrast, many T.2 clones do not effectively lyse antigen- 
pulsed targets, particularly clones derived from certain strains 
of mice, such as BALB/c (35).  Interestingly, as depicted in 
Fig. 4 using two T.0 clones of each subtype, when T.0 ceUs 
were treated with immobilized anti-CD3 mAb, they subse- 
quently displayed markedly decreased lyric activity for OVA- 
pulsed B lymphoma cells compared to untreated cells. This 
effect  was  nearly complete for  the T~0-A clones,  which 
generally lysed less well to begin with (Fig.  4, A  and B). 
Similar  results were obtained with several additional T.0 
clones  derived from BALB/c and DBA/2 mice (data  not 
shown). These observations are in stark contrast to those ob- 
tained with T,1 clones, which when anergized with anti- 
CD3 mAb, retained their cytolytic capability (36, and data 
not  shown).  These results suggest that exposure of T.0 
dones to anergizing stimuli can alter multiple functions in 
those cells, not only their lymphokine  profile. Moreover, they 
suggest that stimulation of T.0 cells via the TCR complex 
might generate a signal that does not occur after stimulation 
of T.1 cells, one which results in disengagement of subse- 
quent cytolytic capability. 
It has been suggested that T.1 cells as a group proliferate 
better than T.2 cells (37). Hence, the effect of pretreatment 
of T.0 clones with anti-CD3 mAb on subsequent antigen- 
specific proliferation of those cells also was examined. Prolifer- 
ation of anergized T.0 cells in response to syngeneic spleen 
cells and OVA was partially reduced, ranging from 10 to 90%, 
compared to control cells (data not shown). These results 
also are consistent with inhibition of IL-2 production after 
exposure to anti-CD3 mAb and predominant utilization of 
IL-4 rather than IL-2 as an autocrine growth factor. 
Surface Phenotype of Anergized T~O Cells,  It was conceiv- 
able that treatment of the T  cell clones with immobilized 
anti-CD3 mAb might alter significantly the expression  of 
surface molecules necessary for activation. Inasmuch as re- 
stimulation of the cells was performed with immobilized anti- 
CD3 mAb, expression of the TCR-cdj8 heterodimer, CD3-e, 
and CD4 was examined. As shown in Fig, 5, anergized T.0 
cells did not express reduced levels of any of these markers, 
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Figure 4.  Effect  ofpretreatment with immob'tlized anti-CD3 mAb on 
the subsequent cytolytic activity of %0 cells. Two T.0-A and Td)-B dones 
were treated for 72 h with immobilized anti-CD3 mAb, collected and 
purified by Ficoll-Hypaque centrifugation, then tested for the ability to 
lyse B lymphoma targets that had previously  been pulsed with OVA. Results 
are expressed as percent specific lysis, and are representative of two ex- 
periments. 
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Figure $.  Effect  of treatment with immobilized  anti-CD3 mAb on ex- 
pression of cell surface molecules. The T.0 clone 34 was isolated directly 
from passage cultures (c),  or treated with immobilized anti-CD3 mAb 
for 72 h (A), then assessed for expression of CD3-e (a), TCR-cx//~ (c), 
or CD4 (D) by flow cytometry. Control samples were stained with irrele- 
vant Ab (FITC-OKT3) (^). Results are expressed as relative fluorescence, 
and are representative of three experiments. the mean fluorescence  of each being comparable to that found 
in resting ceils. The histograms corresponding to the treated 
ceUs are slightly more heterogeneous, probably reflecting the 
relative size increase seen after induction of anergy with anti- 
CD3 mAb. 
The morphologic phenotype of anergic T.0 ceils also was 
examined. The TH1 and Tx2 clones we have  studied are mor- 
phologically dissimilar in that TH2 ceils are typically larger 
and more rounded compared to T.1 cells, which are smaller 
and more dub shaped. This is illustrated in Fig. 6 with pho- 
tographs  of a T.1 done PGL10 (Fig. 4 A) and the proto- 
typic T.2  clone D10.G4.1  (Fig.  4 B),  purified  by Ficoil- 
Hypaque centrifugation after  7 d in passage culture.  The 
T.0 clones resembled TH1 cells, being relatively small and 
dub shaped, although they typically appeared slightly larger 
than T.1  ceils (Fig. 4 C). Interestingly,  after anergy with 
anti-CD3 mAb, the T.0 cells became larger and rounder, ap- 
pearing more like a Tx2 clone (Fig.  4 D).  Similar results 
were observed after induction of anergy of T.1  cells (data 
not shown). After 7 d, they still retained this larger size, as 
if they had arrested in the middle of bhst phase (data not 
shown). These observations suggest that T.1 and T.2 cells 
might possess different cytoskeletal arrangements,  and imply 
that a reorganization of the cytoskeleton might occur after 
induction of the anergic state. 
Altered Signal  Transduction in  Anergized  T.O  Cells,  We 
have reported previously that, in contrast to T~I clones, TH2 
clones manifest little or no detectable devation of [Ca  z  +  ]i or 
inositol phosphates after stimulation via the TCR complex, 
suggesting utilization of a distinct signal transduction mech- 
anism (13). In light of these results, it was of interest  to ex- 
amine the change in [CaZ+]i in T.0 ceils, which share char- 
Figure 6.  Morphology of TH0 cells after induction of anergy with immobilized anti-CD3 mAb. The TM1 clone PGL10 (,4),  the TH2 clone D10 
(B), the %0 clone 34 (C), or the %0 clone after treatment with anti-CD3 mAb for 72 h (D) were purified by Ficoil-Hypaque centrifugation.  They 
were then placed back into wells of a 24-well phte (10% and photographed  with a 35-ram  camera fixed to a microscope. 
486  Anergy of TH0 CeUs Induces TH2 Phenotype acteristics of both mature subsets.  As shown in Fig. 7, after 
stimulation with Con A, T.1 cells responded with a 200- 
300%  elevation in  [Ca2+]i,  whereas T.2  clones showed a 
minimal response.  Interestingly, the T~0 dones exhibited an 
increase in  [CaZ+]i which was  intermediate between that 
seen with T,1 and T~2 cells, ranging from 50 to 120% over 
resting  levels.  The  IFN-'y-producing  Tn0-B  clones  re- 
sponded  with  an  approximately  twofold  greater  rise  in 
[Ca2+]i than the T~0-A cells.  The presence of a readily de- 
tectable calcium elevation in T.0 clones suggests that they 
employ, at least in part, a similar signal transduction apparatus 
to that used in 1".1  cells. 
For comparison, change in [Ca  2+ ]i was also examined in 
resting  splenic CD4 +  T  cells  isolated by positive sorting 
with anti-CD4 mAb (Fig.  7).  Resting CD4 + spleen cells, 
which produce predominantly IL-2 after stimulation via the 
TCR. complex (5), generated a brisk calcium flux in response 
to Con A, similar to that observed with T.1 clones. Similar 
results were obtained using cells enriched by negative deple- 
tion with a cocktail of  anti-CD8, anti-B220, anti-Ig, and anti- 
MAC-1 mAbs (data not shown), suggesting that the anti- 
CD4 mAb used for sorting had no effect on signaling.  If 
T.2 cells indeed differentiate from the IL-2-producing popu- 
lation  of naive CD4 + T  cells,  this result suggests that  as 
they acquire the ability to produce IL-4 and pass  through 
a TO intermediate stage, they gradually lose the capability 
of signaling via the calcium pathway. 
It was of interest to explore the effect of anergizing stimuli 
on signal transduction in T,0 ceils  and determine if there 
were alterations that correlated with the observed changes 
in function.  This was addressed by examining changes in 
[Ca2+]i in treated cells.  The typical vigorous calcium flux 
observed  with  the  representative  T.1  done  PGL10  is 
depicted in Fig. 8 A, and the minimal calcium response ob- 
served with the T.2 done D10 is represented in Fig. 8 B. 
Interestingly, the intermediate calcium response seen with 
Figure 7.  Changes  in [C#+]i in response to TCR ligation of HTL 
subsets. Four HTL clones  representing  each  of the indicated  subsets  were 
collected  from  passage  cultures,  purified  by  Hcoll-Hypaque centtifugation, 
and loaded  with the calcium  indicator  dye Indo-1. CD4  + spleen  cells  were 
isolated by positive  sorting with FITC-conjugated  anti-CD4 mAb and 
also loaded  with Indo-1.  They  were  then  stimulated  with Con A (10 V.g/ml), 
and changes  in fluorescence  were monitored  using a spectrofluorometer. 
Calciura concentrations  were determined  as described  in Materials and 
Methods. Results are expressed  as percent increase  over  baseline values. 
a  representative T.0-B  clone (Fig.  8  C)  was  nearly com- 
pletely abrogated after induction of anergy with anti-CD3 
mAb (Fig.  8 D). Thus, anergic T.0 cells have a blunted ele- 
vation  of [Ca2+]i  upon  restimulation,  similar  to  that  ob- 
served with T.2  clones. 
This response was examined more carefully with several 
additional T.0-A  and T.0-B  clones.  When actual [Ca2+]i 
concentrations were calculated, several conclusions emerged. 
First,  the IFN-3~-producing T.0-B  calls had a lower basal 
[Ca  2+ It compared to the T.0-A dones (Fig.  9).  This result 
is  reminiscent  of observations  made  with  T.1  and  T,2 
clones,  the former having  relatively lower  [Ca2+]i  in  the 
resting state compared to the latter (13).  Second, after pri- 
mary activation via the TCP, complex, the [Ca2+]i for all 
clones approached approximately the same plateau, around 
200 nM in these experiments. Third, after anergy with anti- 
CD3 mAb, the basal [Ca2+]i was markedly devated at '~,200 
riM,  and did not significantly increase after subsequent re- 
stimulation via the TCP, complex (Fig. 9). This signal pheno- 
type is similar to that observed previously with T.2 clones 
(13). Collectively, these results suggest that as HTL develop 
down the T.2 pathway, they acquire an increased basal  in- 
tracellular caldum concentration, which is not increased much 
further when those ceils encounter TCK stimulation. 
Discussion 
Clonal  anergy was  first  described in  a  T.1  done  after 
stimulation with chemically treated spleen calls and specific 
antigenic peptide (14). Subsequently, it was found that anergy 
could be induced by additional stimuli, including antigenic 
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Figure  8.  Anergized  %0 cells  have  a diminished  calcium  response.  The 
1".1 clone  PGL10 (A), the TH2 clone  D10 (B), the T.0 clone 34 isolated 
from passage  culture (C), and the T.0 clone  after  pretreatment  with im- 
mobilized  anti-CD3 mAb (D) were  purified  by Ficoll-I-Iypaque  centrifu- 
gation. They were then loaded  with Indo-1, and calcium  changes  were 
monitored  in response  to Con A (10/~g/ml)  as in Fig. 7. Results  are repre- 
sentative of three experiments. 
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peptide presented either by purified class II MHC proteins 
in planar lipid membranes or by small resting B cells, anti- 
TCR mAbs,  the T  cell mitogen Con A,  and the calcium 
ionophore, Ionomycin (15, 16, 31-33). All these stimuli lack 
the ability to provide a costimulator signal delivered by par- 
ticular APCs that prevents induction of anergy. This cofactor 
may be identical to the cofactor necessary for optimal prolifer- 
ation of T.1  cells (10). In fact, it has been suggested that 
proliferation per se is the event necessary to avoid induction 
of anergy (38).  The fact that Ionomycin alone is sufficient 
for the generation of the unresponsive state suggests that cal- 
cium elevation in the absence of a signal delivered by the 
costimulator molecule is the essential biochemical step during 
the induction phase. 
In contrast to T.1 cells, anergy of T.2 cells with respect 
to IL-4 production has been difficult to demonstrate (18). 
It  was  conceivable that  this  difference was  secondary to 
different signals being generated after engagement of the TCR 
complex in the two cell types. In our present study, immobi- 
lized anti-CD3 mAb, Ionomycin, or purified B cells and an- 
tigen, all were able to induce anergy with respect to IL-2 
but not IL-4 production in T.0 clones. The fact that aner- 
gizing stimuli led to inhibition of expression of one lym- 
phokine gene but not another in the same cells, suggests that 
the anergy effect is specific for IL-2 and not IL-4 gene ex- 
pression.  It  is likely that  IL-4  production by T.2  clones 
cannot be anergized because expression of the IL-4 gene is 
insensitive to the effects of anergizing stimuli. In fact, Iono- 
mycin alone actually stimulates production of IL-4 by T.2 
clones (13).  Other lymphokines that are only partially in- 
hibited after exposure to anergizing stimuli, such as IFN-  7 
and IL-3 (16), probably rely on multiple signaling pathways 
for their expression, only some of which are inhibited in the 
anergic state. 
Recently, other investigators (34) have reported similar in- 
duction of anergy by anti-CD3 mAb with respect to IL-2 
but not IL-4 production in T.0 clones. In that study, it is 
argued that the cells do not acquire a T.2 phenotype because 
the  anergizing  stimulus  also  induces  reduced  ability  to 
proliferate in response to IL-4. However, T.2 cells generally 
proliferate less vigorously in response to antigenic stimula- 
tion than T.1 cells. In addition, we have observed that the 
majority of our clones previously characterized as T.2 cells 
do not proliferate well in response to exogenous IL-4. although 
their modest autocrine proliferation is inhibited by anti-IL-4 
mAb (Gajewski, T., unpublished observations). Therefore, 
the reduced ability to proliferate might not be uncharacteristic 
of T.2 clones, and is not inconsistent with the possibility 
that induction of anergy in T.0 ceils may lead to a TH2-1ike 
phenotype. 
Antigen-specific cytolytic activity also  was inhibited in 
anergic T.0 cells, demonstrating that more than one func- 
tional trait can be significantly affected. Interestingly, cyto- 
lytic activity was  not affected after anergy of several T.1 
clones (36, and Lancki, D. W., and T. Gajewski, unpublished 
observations), nor was it found to be inhibited in anergic 
IL-2-producing CD8 + CTL clones (40).  These results sug- 
gest that the TCR-mediated signals that are coupled to the 
cytolytic machinery in T.1 and T.0 cells may be differen- 
tially influenced by anergizing stimuli.  Alternatively, T.1 
and T.0 cells might employ distinct mechanisms of cytol- 
ysis (27),  only one of which is affected in the anergic state. 
The fact that multiple T.I-like functions were reduced after 
induction of anergy of T.0 cells supports the notion that a 
T.2-1ike  phenotype  is  emerging under  those  conditions. 
Whether or not anergy of T.0 cells renders them better able 
to provide help for B cell proliferation and Ab production 
remains to be examined. 
Anergized  T.0  cells  exhibit  an  elevated basal  level  of 
[Ca2+]i and a blunted calcium flux upon restimulation, sig- 
naling  attributes  also  possessed  by T.2  cells.  Preliminary 
results  have  suggested  that  the  diminished  elevation  of 
[CaZ+]i observed in T.2  clones,  as well as  anergized T.0 
clones, may correlate with decreased detectable PLC-'y1 ex- 
pression (Goldfien, R., J. Imboden, T. Gajewski, and D. Qian, 
unpublished observations). In addition, the pattern of tyro- 
sine phosphorylated substrates seen after TCR ligation of aner- 
gized T.0 clones also is altered, more resembling that of T.2 
cells (Gajewski, T., and D. Qian, unpublished observations), 
implying that multiple aspects of TCR-mediated signal trans- 
duction are modified in anergized T.0 clones. If T.2 cells 
indeed  arise  when  T.0  cells  are  exposed  to  anergizing 
stimuli, these results also suggest the possibility that the sig- 
naling characteristics of T.2 cells may be a secondary event, 
the result of repeated engagement with APCs lacking costimu- 
lator activity, induction of anergy with respect to IL-2 produc- 
tion,  and  downregulation  of  the  Tal-type  signaling 
pathway. Thus, the lack of a calcium flux may correlate with 
the T.2 phenotype, essentially being a marker for their his- 
tory of being activated in the absence of a costimulator signal, 
but might not actually mediate the T.2 phenotype. 
Several APC-derived costimulator molecules and their as- 
sociated receptors have been identified that  may mediate 
costimulation and prevent induction of anergy in T.1 cells. 
CTLA4 (41) and CD28 (42) are two costimulator receptors 
expressed on T lymphocytes, both of which can bind to the 
molecule B7 expressed on activated B lymphocytes and other 
cell types (43).  Heat stable antigen also has been suggested 
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Figure  10.  Model for the ontogeny of T.1 and T.2 calls based on fig- 
naling differences and the concept of anergy. Our results are consistent 
with a modal in which resting naive CD4 § T  cells c~chibit a brisk cal- 
cium flux and produce predominantly  Ib-2 upon primary stimulation. Pri- 
mary activation  gives rise to  the T.0 phenotype,  which has an inter- 
mediate calcium ~ux and produces lymphokines characteristic of both T.1 
and T.2 cells. In the presence of anergizing conditions, this cell loses its 
T.1 attributes and retains characteristics of a T,2 cell. The fact that both 
resting CD4 + splenic T  cells and "1".1 cells exhibit a vigorous calcium 
flux in response to TCP, ligation suggests that the T,1 differentiation 
pathway might proceed independently of the T.0 intermediate. Stimuli 
inducing  differentiation of T.1 cells from T,0 cells are suggested by other 
studies, but remain specuhtive  on the donal level. 
to serve as a receptor for a costimulator molecule (44).  It 
will be of interest to examine the expression and activity of 
these molecules with respect to the various HTL subsets, and 
to determine ff simultaneous ligation of any of these mole- 
cules and the TCR complex can prevent the transition of 
T.0 cells into a T.2 phenotype. 
Several cytokines have been shown to facilitate differentia- 
tion of newly activated HTLs into mature T.1 or T.2 cells. 
IFN-7 appears to favor emergence of a T.1 phenotype (5), 
perhaps by increasing the frequency of T.0 cells that pro- 
duce IFN-3, (see Fig. 2). IL-12 has recently been shown also 
to promote generation of a T.1 phenotype, by a mechanism 
that may depend upon IFN-3' activity (45). Conversely, the 
presence of IL-10 and IL-4 during HTL activation appears 
to result in preferential emergence of a T.2 phenotype (46). 
It is unclear whether these cytokines act directly on T lym- 
phocytes, or indirectly via APCs, to exert all of their dif- 
fa~mtiation-inducing effects. It is conceivable that expression 
of costimulator molecules on the APC population, or respon- 
siveness of the T ceils to costimulation, is modulated by these 
cytokines, thus determining ff the developing T  cell is ex- 
posed to stimulation via the TCR alone or simultaneously 
with a costimulatory signal. These possibilities remain to be 
examined. 
A proposed model for the ontogeny of T.1 and T.2 cells 
with the potential influence of anergizing stimuli is summa- 
rized in Fig.  10. Naive CD4 + T cells, when first activated 
via the TCR. complex, respond with a brisk elevation  in 
[Ca2+]i and produce predominantly IL-2.  This primary ac- 
tivation event induces a differentiation process  that allows 
the cell to express additional lymphokine genes, perhaps alI 
lymphokine genes that HTL are capable of transcribing,  thus 
giving rise to the T.0 phenotype. The presence of IFN-~' 
during this period may determine if the T.0 cell itself ac- 
quires the ability to produce IFN-% Associated with an ex- 
panded lymphokine  program is cytolytic activity, and moder- 
ately altered  signal  transduction, manifested by a reduced 
calcium flux. It is possible that the T.0 cell expresses quan- 
titatively hss of the T.1 signaling enzymes, or that acquisi- 
tion of T.2 traits inhibits some aspects of T~I signaling. 
When cells at the T.0 stage are stimulated in the absence 
of a costimulator molecule, the T.1 program might be in- 
hibited, giving rise to a I".2 phenotype. These calls then 
have reduced cytolytic capability and lack a substantial cal- 
cium flux. In addition, the basal levd of [Ca2§  rises as the 
developing cell becomes more T.2-1ike.  Such a  situation 
might occur when resting B cells are the predominant APCs 
participating in the ongoing immune response, as these calls 
can induce anergy of T.1 clones (32, 33) and inhibit the T.1 
characteristics  of T.0 clones (see Fig.  1). Mature T.2 calls, 
therefore,  retain the ability to proliferate  in the absence of 
costimulator signals, and B cells can serve as optimal APCs 
for this cell subset (10). Conversely, although not examined 
in this study, cells of the T.1 phenotype may arise when the 
T.0 ceils are stimulated in the presence of a costimulator 
signal, perhaps under the additional influence of the cytokines 
IL-12 and IL-% However, it is interesting that both naive 
HTL and mature T.1 cells exhibit a vigorous calcium flux, 
whereas T.0 cells have one of intermediate magnitude. This 
result suggests the possibility that T.1 cells may arise di- 
rectly from naive CD4 + HTL precursors,  and that the T~0 
call is only an intermediate in the differentiation pathway of 
T.2 ceils. These aspects of the ontogenetic model have yet 
to be examined. 
The cell culture model for inducing clonal anergy prob- 
ably reflects a mechanism by which peripheral tolerance of 
T lymphocytes can be achieved in vivo (17, 47). Application 
of these concepts might provide a means by which to deliber- 
ately induce specific T cell unresponsiveness during situations 
of undesirable T ceil activation, such as autoimmune diseases 
or ailogeneic transplant. However, our results  suggest that 
attempts at inducing specific anergy in vivo, after an immune 
response has already been initiated and a T.0 phenotype has 
been generated, might resu/t not in complete  anergy, but rather 
a T.2-centered immune response. In fact, it has been demon- 
strated that neonatal exposure to alloantigens results, not in 
complete tolerance, but in the generation of cells that pro- 
duce IL-4 (48).  Additional in vivo models will need to be 
explored to further test these hypotheses. 
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